Riverbridge Partners LLC Has $9.17 Million Holdings in OrthoPediatrics Corp. (NASDAQ:KIDS)

Riverbridge Partners LLC lessened its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 4.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 372,478 shares of the company's stock after selling 18,296 shares during the quarter. Riverbridge Partners LLC owned approximately 1.53% of OrthoPediatrics worth $9,174,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP boosted its holdings in shares of OrthoPediatrics by 20.2% during the fourth quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock worth $24,601,000 after acquiring an additional 178,078 shares during the period. Wasatch Advisors LP boosted its stake in shares of OrthoPediatrics by 47.2% in the fourth quarter. Wasatch Advisors LP now owns 696,318 shares of the company's stock valued at $16,141,000 after buying an additional 223,217 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of OrthoPediatrics by 29.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company's stock valued at $15,576,000 after buying an additional 152,681 shares during the period. AWM Investment Company Inc. boosted its stake in shares of OrthoPediatrics by 14.8% in the fourth quarter. AWM Investment Company Inc. now owns 516,794 shares of the company's stock valued at $11,979,000 after buying an additional 66,779 shares during the period. Finally, Millennium Management LLC bought a new stake in shares of OrthoPediatrics in the fourth quarter valued at approximately $9,798,000. Institutional investors own 69.05% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Needham & Company LLC reiterated a "buy" rating and issued a $42.00 price target on shares of OrthoPediatrics in a research note on Thursday, May 8th. Wall Street Zen cut OrthoPediatrics from a "hold" rating to a "sell" rating in a research note on Friday, June 6th. Piper Sandler cut their price target on OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating for the company in a research note on Thursday, May 8th. Stifel Nicolaus cut their target price on OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating for the company in a research note on Wednesday, March 5th. Finally, Truist Financial cut their target price on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research note on Friday, April 11th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $35.83.

OrthoPediatrics Stock Performance

NASDAQ KIDS opened at $20.15 on Friday. The company has a market capitalization of $489.44 million, a price-to-earnings ratio of -11.51 and a beta of 1.08. OrthoPediatrics Corp. has a twelve month low of $19.52 and a twelve month high of $35.99. The stock has a fifty day simple moving average of $21.37 and a 200 day simple moving average of $23.18. The company has a quick ratio of 2.99, a current ratio of 6.19 and a debt-to-equity ratio of 0.21.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). The company had revenue of $52.41 million during the quarter, compared to analyst estimates of $51.68 million. OrthoPediatrics had a negative net margin of 19.15% and a negative return on equity of 7.03%. Sell-side analysts expect that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.